Twist Bioscience (TWST) Share-based Compensation (2017 - 2026)

Twist Bioscience (TWST) has reported Share-based Compensation for 10 consecutive years, with $18.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 13.2% year-over-year to $18.2 million in Q2 2026; TTM through Jun 2026 was $78.0 million, a 28.4% increase from a year earlier, with the FY2025 full-year figure at $64.5 million, up 26.58% from the prior year.
• Share-based Compensation was $18.2 million for Q2 2026 at Twist Bioscience, down from $18.9 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $24.8 million in Q4 2025 and troughed at -$2.3 million in Q4 2022.
• A 5-year average of $12.6 million and a median of $12.3 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 103.21% in 2022 and surged 573.98% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at -$2.3 million in 2022, then surged by 573.98% to $11.0 million in 2023, then rose by 8.81% to $12.0 million in 2024, then surged by 106.6% to $24.8 million in 2025, then dropped by 26.63% to $18.2 million in 2026.
• The last three Share-based Compensation figures came in at $18.2 million (Q2 2026), $18.9 million (Q1 2026), and $24.8 million (Q4 2025), per Business Quant data.